How Evrysdi helped patients with later-onset SMA

SUNFISH is a 2-part, multicenter trial to investigate the efficacy, safety, and tolerability of Evrysdi in children and adults with Type 2 or Type 3 SMA. Learn more about the SUNFISH trial design.
 

Motor function

Upper limb

Connect with a Genentech representative